docTLDR

The National Board of Examinations (NBE) has declared the NEET PG 2025 results, confirming Dr Pooshan Mohapatra from SCB Medical College and Hospital, Cuttack, as All India Rank 1 with 707 out of 800 marks. The official merit list highlights the top five scorers from diverse medical colleges, reflecting intense competition. Qualified candidates can now participate in the Medical Counselling Committee (MCC) counselling process.

Doctors at Acharya Bhikshu Hospital, Delhi, have accused BJP MLA Harish Khurana and his aides of physically assaulting and abusing an MBBS trainee in the emergency ward after being asked to wait for treatment. The incident, which reportedly involved threats and manhandling, has sparked widespread condemnation from medical associations, with calls for immediate arrest and stronger hospital security. Khurana has yet to respond to the allegations.

NBEMS will, for the first time, release NEET PG 2025 answer keys, raw scores, and normalisation formula on its website, following a Supreme Court directive to ensure transparency in multi-shift exams. Over 2.42 lakh candidates appeared for the August 3 exam. Candidates can access their answer keys and responses via applicant login. Individual scorecards will be available from August 29, 2025.

A prespecified post hoc analysis of the HOST-IDEA trial found that in patients with chronic kidney disease (CKD) undergoing PCI with third-generation drug-eluting stents, 3- to 6-month dual antiplatelet therapy (DAPT) was comparable to 12-month DAPT for net adverse clinical events, target lesion failure, and major bleeding, regardless of renal function. This suggests shorter DAPT may be as safe and effective as longer regimens for CKD patients post-PCI.

A 69-year-old New Zealander, after exhausting treatment options for multiple myeloma at home, travelled to Bengaluru for CAR T-cell therapy at Cytecare Hospitals. Indian regulations and expertise enabled access to this advanced, potentially life-saving treatment, highlighting Bengaluru's emergence as a global destination for cutting-edge oncology care. The case underscores India's growing role in medical tourism for complex cancer therapies.

Between 2022 and 2024, 429 doctors resigned from 20 AIIMS institutes, with Delhi AIIMS seeing the highest exits. Nearly one-third of faculty posts remain vacant nationwide, severely impacting patient care and research. Government stopgap measures like hiring retired or visiting faculty have failed to address the underlying issues, including poor pay, lack of facilities, and inadequate support for research.

A US-based techie with atlantoaxial dislocation and quadriparesis regained mobility after Bengaluru doctors at Aster Whitefield Hospital used mixed reality technology to plan and execute a high-risk spinal surgery. The team, led by Dr Satish Rudrappa and Dr Ramachandran G, created a 3D hologram of the patient’s spine for precise navigation, enabling a successful operation and rapid recovery. The patient has resumed an active lifestyle, including sports.

A Rajya Sabha parliamentary committee has recommended expanding AYUSH-based healthcare services nationwide to promote integrative oncology, citing limited penetration of Ayurveda, Homeopathy, Unani, and Siddha in cancer care. The panel urges establishing dedicated AYUSH cancer care institutions in every state and UT, and calls for cancer to be declared a notifiable disease for improved data, surveillance, and policy planning. Currently, cancer data covers only 18% of the population, hindering...

CAR-T cell therapy has demonstrated superior efficacy over standard chemoimmunotherapy and autologous stem cell transplantation as a second-line treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Recent phase 3 trials, including ZUMA-7 and TRANSFORM, showed improved event-free survival and higher complete response rates with CAR-T products like axi-cel and liso-cel. These findings are shifting clinical practice, with CAR-T now recommended for patients who relapse with...

The United Doctors Front has filed a plea in the Delhi High Court challenging the National Medical Commission’s 2025 regulations that allow up to 30% of faculty positions in core MBBS subjects (Anatomy, Biochemistry, Physiology, Pharmacology, Microbiology) to be filled by medical MSc or PhD holders. The petition alleges this dilutes medical education and violates statutory provisions. The case was listed for hearing on August 21, 2025.

A Mass General Brigham-led study found that generative AI scribes, which record patient visits and draft clinical notes for review, led to a 21.2% absolute reduction in physician burnout at 84 days and a 30.7% increase in documentation-related wellbeing at Emory Healthcare. Over 3,000 providers now routinely use these tools, reporting more face-to-face patient time and improved work-life balance. Some users noted increased note-writing time or limited utility for certain specialties, highligh...

A prespecified secondary analysis of the EAST-AFNET 4 randomized clinical trial found that early rhythm control therapy in atrial fibrillation (AF) patients significantly reduces cardiovascular death, stroke, heart failure hospitalization, or acute coronary syndrome compared to usual care. Importantly, these benefits and safety are consistent regardless of diabetes or obesity status, supporting early rhythm control as an effective strategy for diverse AF populations.

India's MBBS seats have surged 39% since 2020, now at 115,900, with PG seats at 53,960. While this expansion aims to improve healthcare access, experts warn of challenges in maintaining educational quality, clinical exposure, and equitable doctor distribution, especially in rural areas.

WHO has updated its guidance on oseltamivir, an oral antiviral for influenza. The latest pharmacokinetic data may impact dosing and patient selection, especially in high-risk groups. Indian doctors should review the revised recommendations to optimize antiviral use during seasonal and pandemic influenza outbreaks.

The 2024 WHO guidelines recommend a reduced zinc dose (5 mg daily for up to 14 days) for children up to 10 years with acute or persistent diarrhea to minimize vomiting. Antibiotics are discouraged for acute watery diarrhea except with visible blood, where ciprofloxacin is first-line. Oral amoxicillin remains first-line for pneumonia in children aged 2–59 months, suitable for community management.